1. The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin
   Emil Andreev et al, 2016, Scientific Reports CrossRef
2. Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents
   Jitka Fucikova et al, 2022, Trends in Cancer CrossRef
3. Novel insights on use of doxorubicin to treat chemoresistant TNBC by Immunotherapy
   Hsieh Tze-Chen et al, 2020, International Journal of Immunotherapy and Cancer Research CrossRef
4. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
   Stella Amarachi Ihim et al, 2022, Frontiers in Immunology CrossRef
5. Cancer-testis antigen cyclin A1 is broadly expressed in ovarian cancer and is associated with prolonged time to tumor progression after platinum-based therapy
   Ruza Arsenic et al, 2015, BMC Cancer CrossRef
6. Taxol: Mechanisms of action against cancer, an update with current research
   Pei Tee Lim et al, 2022, Paclitaxel CrossRef
7. Circulating exosomal microRNAs reveal the mechanism of Fructus Meliae Toosendan-induced liver injury in mice
   Jie Zheng et al, 2018, Scientific Reports CrossRef
8. Epithelial ovarian cancer stem-like cells expressing α-gal epitopes increase the immunogenicity of tumor associated antigens
   Xiaofen Yao et al, 2015, BMC Cancer CrossRef